Yarrow Bioscience (YARW) Other financing activities (2018 - 2021)
Yarrow Bioscience's (YARW) quarterly Other financing activities came in at $285000.0 in Q4 2021, up 122.66% YoY from $128000.0 in Q4 2020, and up 2950.0% on a QoQ basis from -$10000.0 in Q3 2021.
Yarrow Bioscience (YARW) Other financing activities (2018 - 2021) Analysis & Trends
Yarrow Bioscience (YARW) has 4 years of Other financing activities data on file, last reported at $285000.0 in Q4 2021.
- Quarterly Other financing activities rose 122.66% year-over-year to $285000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $522000.0 (up 68.39% YoY) and the FY2021 annual result came in at $522000.0, up 68.39% from the prior year.
- Other financing activities advanced to $285000.0 in Q4 2021, from -$10000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $376000.0 in Q1 2021 to a low of -$129000.0 in Q2 2021.
- A 4-year average of $118692.3 and a median of $82000.0 in 2020 frame the typical range for Other financing activities.
- The widest YoY moves for Other financing activities: up 775.0% in 2020, down 2100.0% in 2020.
- Tracing YARW's Other financing activities over 4 years: stood at $346000.0 in 2018, then declined by 7.23% to $321000.0 in 2019, then sank by 60.12% to $128000.0 in 2020, then soared by 122.66% to $285000.0 in 2021.
- The last three Other financing activities figures came in at $285000.0 (Q4 2021), -$10000.0 (Q3 2021), and -$129000.0 (Q2 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Yarrow Bioscience | 31.25 Mn | 8.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 285,000.00 |
| Dec 31, 2021 | 285,000.00 |
| Sep 30, 2021 | -10,000.00 |
| Sep 30, 2021 | -10,000.00 |
| Jun 30, 2021 | -129,000.00 |
| Jun 30, 2021 | -129,000.00 |
| Mar 31, 2021 | 376,000.00 |
| Mar 31, 2021 | 376,000.00 |
| Dec 31, 2020 | 128,000.00 |
| Dec 31, 2020 | 128,000.00 |
| Sep 30, 2020 | 82,000.00 |
| Sep 30, 2020 | 82,000.00 |
| Jun 30, 2020 | -40,000.00 |
| Jun 30, 2020 | -40,000.00 |
| Mar 31, 2020 | 140,000.00 |
| Mar 31, 2020 | 140,000.00 |
| Dec 31, 2019 | 321,000.00 |
| Dec 31, 2019 | 321,000.00 |
| Sep 30, 2019 | 26,000.00 |
| Sep 30, 2019 | 26,000.00 |